Company Filing History:
Years Active: 2007-2010
Title: Ruth Tenbrink: Innovator in Alzheimer's Disease Treatment
Introduction
Ruth Tenbrink is a notable inventor based in Labadie, MO (US). She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of Alzheimer's disease. With a total of 2 patents, her work focuses on developing compounds that inhibit beta-secretase, an enzyme linked to the progression of Alzheimer's.
Latest Patents
Ruth's latest patents include innovative compounds such as N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives. These compounds are designed to inhibit beta-secretase and are useful in treating various disorders, including Alzheimer's disease. Another significant patent involves benzamide 2-hydroxy-3-diaminoalkanes, which are also aimed at treating Alzheimer's and related diseases. These compounds are effective in reducing A beta peptide formation, which is crucial for developing effective treatments.
Career Highlights
Throughout her career, Ruth has been associated with Elan Pharmaceuticals, Inc., where she has played a vital role in research and development. Her work has been instrumental in advancing the understanding and treatment of Alzheimer's disease.
Collaborations
Ruth has collaborated with notable colleagues such as Varghese John and Roy K Hom. These partnerships have enhanced her research efforts and contributed to the success of her inventions.
Conclusion
Ruth Tenbrink's innovative work in the pharmaceutical industry highlights her commitment to addressing critical health issues like Alzheimer's disease. Her patents reflect her dedication to improving treatment options for patients, making her a significant figure in the field of medical research.